Uttarakhand STF busts fake pharma factory in Bazpur, seizes 1 lakh tablets
Synopsis
Key Takeaways
The Uttarakhand Special Task Force (STF), in coordination with the Drug Administration Department, on Sunday raided and dismantled a counterfeit pharmaceutical manufacturing unit operating under the name 'Kovil Biotech' in the Bazpur industrial area of Udham Singh Nagar. The syndicate was producing and distributing fake allopathic and life-saving medicines bearing the brand names of established pharmaceutical companies — all without a valid drug manufacturing licence.
What Was Seized
Investigators recovered approximately 1 lakh tablets and 15,000 bottles of syrups intended for treating conditions including acidity, pain, neurological disorders, prostate issues, antibiotic requirements, and calcium and iron deficiencies. The counterfeit medicines carried stamps of reputed firms including STADMED, Macleods, Intas, and Sun Pharma.
Beyond medicines, the raid also uncovered a significant cache of illicit liquor: 1,632 quarters of McDowell's No. 1, 1,016 bottles of III RCS liquor, 1,000 empty glass bottles, and Uttarakhand Excise holograms. Packaging machinery — including filling, sealing, and labelling equipment — along with stainless steel tanks were also confiscated.
How the Operation Was Run
According to officials, Kovil Biotech was operating under the cover of Ayurvedic and food licences to manufacture allopathic drugs — a deliberate misuse of regulatory categories to evade scrutiny. The raid was triggered by a tip-off and specific intelligence inputs, officials said.
One person, identified as Dhirendra, was arrested from the premises. During questioning, Dhirendra reportedly admitted to sourcing illicit liquor from Haryana for distribution within Uttarakhand — indicating the syndicate's activities extended well beyond pharmaceutical counterfeiting.
Legal Action Taken
Following the recoveries, police registered a case against the accused at the Bazpur police station under the Drugs and Cosmetics Act and relevant sections of the Bharatiya Nyaya Sanhita (BNS). The STF has launched a wider investigation to identify and apprehend senior figures or larger syndicates connected to the network.
Why This Matters
The operation exposes a troubling vulnerability in India's pharmaceutical supply chain: counterfeit medicines mimicking trusted brands can reach patients who have no means of verifying authenticity. Life-saving drugs — antibiotics, neurological medications — produced in unlicensed facilities with unverified ingredients pose direct health risks. Notably, the use of Ayurvedic and food licences as regulatory cover suggests a deliberate exploitation of oversight gaps between different licensing authorities. The STF's ongoing probe will be closely watched to determine how deep the supply network runs.